This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Why Aren't We Preventing the Preventable? Updates in Meningococcal B and Other Vaccine Hot Topics

Why Aren't We Preventing the Preventable? Updates in Meningococcal B and Other Vaccine Hot Topics

Format

Expert Perspective

Time to Complete

1 hour

Released

May 26, 2017

Expires

May 25, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour (1.00 of which is eligible for pharmacology credit)
1.00 / AAP Credit

Accredited Provider



Provided by Boston University School of Medicine

Commercial Supporter

This educational activity is supported by an educational grant from GlaxoSmithKline.

Program Description

Given how disabling diseases can be that could have been prevented with vaccination, it is essential that healthcare workers delivering vaccinations enhance their standards of care in practice in order to deliver the highest rates of preventative care. Learn how you can initiate practice changes so as to improve immunization rates for your patients who are currently scheduled for the MnB vaccination. We will also touch on information specific to maternal health and retail clinic vaccination.

Intended Audience

Pediatricians, primary care physicians, OB-GYNs, infectious disease specialists, nurse practitioners (NPs), physician assistants (PAs), nurses and other clinicians who care for patients who are scheduled to receive the Meningococcal B vaccine, as well as those clinicians who routinely care for expectant mothers

Educational Objectives

Upon completion of these activities, participants should be better able to:

  • Discuss the epidemiology of MnB in the United States and the profiles of patients at greatest risk for this vaccine-preventable disease
  • Describe recent 2015 MnB immunization updates made by the Advisory Committee on Immunization Practices (ACIP) and the rationale behind a category B recommendation
  • Examine the mechanism of action, contraindications, and adverse effect profiles of current MnB vaccines
  • Recognize and respond to the opportunity to counsel and screen expectant mothers for recommended immunizations

Conflict Of Interest Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to activity participants prior to the start of the educational activity.

Faculty

Stephen I. Pelton, MD -
Course Director

Professor of Pediatrics
Boston University School of Medicine
Professor of Epidemiology
Boston University School of Public Health
Director, Section of Pediatric Infectious Diseases
Boston Medical Center, Boston, MA

Dr. Pelton receives Grant/ Research/Clinical Trial Support from Pfizer; Merck and Cempra. He is a Consultant for Pfizer, GSK, Sanofi and Sequiris.

Carole Moloney, RN, MSN, CPNP
Clinical Instructor of Pediatrics
Boston University School of Medicine
Pediatric Infectious Diseases
Boston Medical Center, Boston, MA

Carol Moloney, RN MSN CPNP is a consultant for Sanofi.

Amanda Smith, MD – Course Co-Director
Internal Medicine/Pediatrics
University of Louisville School of Medicine, Louisville, KY

Dr. Smith has no relevant relationships to disclose.

Patti Ann Collins, DNP MSN/MBA, RN
CNE Course Advisor
Boston University School of Medicine CME/CNE
Boston, MA

Patti Ann Collins, DNP MSN/MBA, RN, Lead Nurse Planner and CNE Course Advisor has no relevant relationships to disclose.

Accredited Provider Disclosure

Planning Committee:
Sheldon Kaplan, MD
, faculty, receives grant/research/ clinical trial support from Pfizer, Cubist, and Forest Lab.

Gary S. Marshall, MD is on the advisory board and an investigator for GSK, Merck, Novartis, Pfizer and Seqirus. He is a speaker for Pfizer and Sanofi.

Elizabeth Drury, Dana Frazier, and Julie White, planning committee members, have no relevant relationships to disclose.

Lee Wetzler, MD, content contributor, is an advisor for GSK.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAP Credit
This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact Hours: 1.00 all of which are eligible for pharmacology credit.

Designation Statement

Contact Hours: 1.00 (1.00 of which is designated for pharmacology credit)

Disclosure of Unlabeled Use

This activity does not include discussion of off-label use.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue